Most Common Side Effects of Venlafaxine (Effexor)
Nausea is the most common side effect of venlafaxine (Effexor), occurring in approximately 37% of patients taking the medication compared to 11% in placebo groups. 1
Primary Side Effect Profile
Venlafaxine's side effect profile is characterized by several common adverse events:
Gastrointestinal effects:
Neurological effects:
Sexual dysfunction:
Discontinuation Rates Due to Side Effects
Nausea and vomiting are the most common reasons for discontinuation of venlafaxine in clinical trials 2. The FDA label reports that approximately 19% of patients discontinue treatment due to adverse events 1. The most common side effects leading to discontinuation include:
- Nausea (6% vs 1% for placebo) 1
- Somnolence (3% vs 1% for placebo) 1
- Insomnia (3% vs 1% for placebo) 1
- Dizziness (3% vs <1% for placebo) 1
Dose-Dependent Side Effects
Several side effects of venlafaxine show dose-dependency:
- Cardiovascular effects: Blood pressure elevation is more common at higher doses, particularly above 300 mg/day 3
- Gastrointestinal effects: Nausea and vomiting have a higher incidence compared to other SSRIs, especially at high doses 3
Special Considerations
Cardiovascular Effects
Venlafaxine may be associated with an increased risk for cardiovascular events 2, including:
- Dose-dependent increases in blood pressure 3
- Potential cardiac conduction abnormalities including arrhythmias, extrasystoles, and tachycardia at high doses 3
Withdrawal Syndrome
Abrupt discontinuation of venlafaxine commonly leads to withdrawal symptoms including:
Comparison to Other Antidepressants
Venlafaxine has a side effect profile similar to SSRIs but with some notable differences:
- Higher incidence of nausea and vomiting than other SSRIs 2, 3
- More likely to cause blood pressure elevation than SSRIs 3, 4
- Similar rates of sexual dysfunction to SSRIs 2
Clinical Implications
When prescribing venlafaxine, clinicians should:
- Warn patients that nausea is the most common side effect, occurring in over one-third of patients
- Monitor blood pressure regularly, especially when initiating treatment or increasing dose
- Consider gradual titration to minimize gastrointestinal side effects
- Implement a tapering schedule when discontinuing to prevent withdrawal syndrome
- Be aware that most side effects emerge within the first two weeks of treatment but often persist during continued treatment 5